Patents
Patents for C07K 19 - Hybrid peptides (29,428)
03/2011
03/09/2011EP2292651A1 Methods and compositions for the prevention and treatment of anemia
03/09/2011EP2292650A1 Methods and compositions for the prevention and treatment of anemia
03/09/2011EP2292641A2 Expression in filamentous fungi of protease inhibitors and variants thereof
03/09/2011EP2292301A2 Anti-interferon-alpha antibodies
03/09/2011EP2292273A2 Remodeling and glycoconjugation of peptides
03/09/2011EP2292271A2 Remodelling and glycoconjugation of an antibody
03/09/2011EP2292249A1 Non-cytotoxic protein conjugates
03/09/2011EP2292088A1 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
03/09/2011EP2291400A1 Method of diagnosis of infection by mycobacteria and reagents therefor
03/09/2011EP1355918B1 Recombinant protective protein from $i(streptococcus pneumoniae)
03/09/2011EP1315513B1 "pseudo"-native chemical ligation
03/09/2011EP1181320B1 Somatic transgene immunization and related methods
03/08/2011US7902349 Nucleic acids encoding protective epitopes of adenyl cyclase-haemolysin (AC-Hly)
03/08/2011US7902149 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
03/08/2011US7901689 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
03/03/2011WO2011025158A2 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
03/03/2011WO2011024887A1 Conjugate containing cyclic peptide and method for producing same
03/03/2011WO2011024748A1 Modified peptide vaccine derived from influenza m2
03/03/2011WO2010148496A8 Lipidated tumor- associated antigens and immunotherapeutic compositions
03/03/2011WO2010126319A3 Lipopeptide with specific affinity to the fc region of an antibody, and antigen-recognizing lipid nanoparticle comprising same
03/03/2011WO2010123290A3 In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasing in vivo half-life using same
03/03/2011WO2010107825A3 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
03/03/2011WO2010104748A3 Antigen presenting cell targeted anti-viral vaccines
03/03/2011WO2010104357A3 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy
03/03/2011US20110053842 Targeted therapeutics based on engineered proteins that bind egfr
03/03/2011CA2772572A1 Bispecific immunocytokine dock-and-lock (dnl) complexes and therapeutic use thereof
03/03/2011CA2771328A1 Cofactors for thrombin activation of factor vii and uses thereof
03/03/2011CA2770351A1 Compositions and methods of use of immunotoxins comprising ranpirnase (rap) show potent cytotoxic activity
03/02/2011EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells
03/02/2011EP2288624A2 Compositions and methods for inhibiting shiga toxin and shiga-like toxin
03/02/2011EP1650225B1 Hetero type pentamer recombinant vaccine
03/02/2011EP1351992B1 Hybrid peptides for treatment of bacteremia and septicemia
03/02/2011CN1927888B Recombination albumen of GLP-1 and analogue thereof and human lysozyme fusion and application thereof
03/01/2011US7897842 GnTIII expression in plants
03/01/2011US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors
03/01/2011US7897726 Fluorescent proteins from Aequorea coerulscens and methods for using the same
03/01/2011US7897158 Recombinant toxin fragments
03/01/2011US7897157 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types
03/01/2011US7897151 Anti-IgE vaccines
03/01/2011CA2339331C Expression and export of angiogenesis inhibitors as immunofusins
02/2011
02/24/2011WO2011020320A1 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof
02/24/2011WO2011020183A1 Screening of protein candidates
02/24/2011WO2010117750A3 Engineering broad-spectrum disease resistance against haustorium-forming pathogens using rpw8 as a delivery vehicle
02/24/2011WO2010115172A3 Antigenic peptide of hsv-2 and methods for using same
02/24/2011WO2010104749A3 Antigen presenting cell targeted cancer vaccines
02/24/2011WO2010040508A8 Bispecific anti-vegf/anti-ang-2 antibodies
02/24/2011US20110046342 Tumor suppressor activating polypeptides and uses thereof
02/24/2011US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
02/24/2011US20110045012 Anti-atheroma vaccine
02/24/2011US20110045007 Fusion or linked proteins with extended half life
02/24/2011CA2771606A1 Methods of using cd44 fusion proteins to treat cancer
02/24/2011CA2771464A1 Screening of protein candidates
02/24/2011CA2769619A1 Targeted immunoconjugates
02/23/2011EP2287316A1 Antigenic polypeptides
02/23/2011EP2287300A1 Bacterial toxin vaccine
02/23/2011EP2287191A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
02/23/2011EP2287190A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
02/23/2011EP2285969A1 Process, vectors and engineered cell lines for enhanced large-scale transfection
02/23/2011EP1960427B1 Multimeric fc receptor polypeptides
02/23/2011EP1652934B1 Improved method of amplifying atp and use thereof
02/23/2011CN101979594A Influenza virus hemagglutinin fusion peptide-containing targeted recombinant molecule gene, protein encoded thereby and application thereof
02/23/2011CN101979593A Immunotoxin, and preparation method and use thereof
02/23/2011CN101979505A Method and special engineering bacteria for producing N-terminal acetyl protein or polypeptide
02/23/2011CN101979413A Peptide purification by means of metal ion affinity chromatography
02/23/2011CN101979404A Conserved neutralizing epitope mimic peptide of H5 subtype avian influenza viruses and use thereof
02/22/2011US7893204 Attractin/mahogany-like polypeptides
02/22/2011US7892834 Cellular signal-responsive gene transcriptional regulation system
02/22/2011US7892560 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
02/22/2011US7892554 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents
02/22/2011CA2470564C Recombinant polypeptides
02/22/2011CA2435503C Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
02/22/2011CA2329772C Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
02/17/2011WO2011020045A1 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
02/17/2011WO2011020033A2 Engineered proteins including mutant fibronectin domains
02/17/2011WO2011019081A1 Light-receiving channel rhodopsin having improved expression efficiency
02/17/2011WO2011017910A1 Fusion protein mixture for inducing human pluripotent stem cell and preparation method thereof
02/17/2011WO2010104747A3 Antigen presenting cell targeted vaccines
02/17/2011US20110041190 Novel chimeric proteins
02/17/2011US20110039780 Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
02/17/2011US20110039758 Molecular Interactions in Neurons
02/17/2011US20110038912 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces
02/17/2011US20110038887 Novel Vaccine Against Trypanosoma Cruzi Infection
02/17/2011US20110038868 Il-17 homologous polypeptides and therapeutic uses thereof
02/17/2011US20110038866 Improved fibronectin-based binding molecules and uses thereof
02/17/2011US20110038865 Antibody- endostatin fusion protein and its variants
02/17/2011US20110038834 Novel avian cytokines and genetic sequences encoding same
02/17/2011CA2770822A1 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
02/16/2011EP2284270A2 Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
02/16/2011EP2284195A1 Fusion proteins useful for detecting analytes
02/16/2011EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides
02/16/2011CN101977932A Engineered antibody constant domain molecules
02/16/2011CN101977623A Use of therapeutic peptides for the treatment and prevention of cancer
02/16/2011CN101974553A Method for constructing in-vitro aggregation model of associated protein polyQ of Huntington's disease
02/16/2011CN101974090A GLP-1 analog fusion proteins
02/16/2011CN101974089A Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection
02/15/2011US7888490 Site-directed mutagenesis of the native genes of the toxin proteins, Protective Antigen, Lethal Factor and Edema Factor, using polymerase chain reaction; expression and purification
02/15/2011US7888470 Chimeric binding protein for use in identifying compounds which respond to umami taste stimuli and sweet taste stimuli
02/15/2011US7888311 for decontaminating soils and water; for detecting and treating people contaminated by uranium
02/15/2011US7888291 Substrates and assays for β-secretase
02/15/2011US7888071 DNA encoding IL-2 fusion proteins with modulated selectivity
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 295